Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | https://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT |
id |
doaj-efa130d8f10e493b89976379d6f63e5f |
---|---|
record_format |
Article |
spelling |
doaj-efa130d8f10e493b89976379d6f63e5f2020-11-25T00:58:51ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-06-012016Issue 11587158827628Parkinson's disease managing reversible neurodegeneration [Corrigendum]Hinz MStein ACole TMcDougall BWestaway MHinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original articlehttps://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hinz M Stein A Cole T McDougall B Westaway M |
spellingShingle |
Hinz M Stein A Cole T McDougall B Westaway M Parkinson's disease managing reversible neurodegeneration [Corrigendum] Neuropsychiatric Disease and Treatment |
author_facet |
Hinz M Stein A Cole T McDougall B Westaway M |
author_sort |
Hinz M |
title |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
title_short |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
title_full |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
title_fullStr |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
title_full_unstemmed |
Parkinson's disease managing reversible neurodegeneration [Corrigendum] |
title_sort |
parkinson's disease managing reversible neurodegeneration [corrigendum] |
publisher |
Dove Medical Press |
series |
Neuropsychiatric Disease and Treatment |
issn |
1178-2021 |
publishDate |
2016-06-01 |
description |
Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original article |
url |
https://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT |
work_keys_str_mv |
AT hinzm parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT steina parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT colet parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT mcdougallb parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum AT westawaym parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum |
_version_ |
1725220212717912064 |